Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
IN |
|
ADMA Biologics Inc
NASDAQ:ADMA
|
US |
|
W
|
Willis Towers Watson PLC
SWB:WTY
|
UK |
|
C
|
Coca Cola HBC AG
OTC:CCHGY
|
CH |
|
Severstal' PAO
MOEX:CHMF
|
RU |
|
A
|
AdCapital AG
SWB:ADC
|
DE |
|
Mhp Se
LSE:MHPC
|
UA |
|
N
|
Newcrest Mining Ltd
XHAM:NMA
|
AU |
|
S
|
Sungei Bagan Rubber Company Malaya Bhd
KLSE:SBAGAN
|
MY |
|
J
|
JSR Corp
SWB:JYR
|
JP |
|
Jardine Matheson Holdings Ltd
SGX:J36
|
HK |
|
Ingredion Inc
NYSE:INGR
|
US |
Bankruptcy Probability
Dr. Lal PathLabs Ltd's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Dr. Lal PathLabs Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IN |
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
266.1B INR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
129.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
74.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
78.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
21.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
17.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
13.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
12.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Dr. Lal PathLabs Ltd's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Dr. Lal PathLabs Ltd has total debt of 1.5B INR. This includes both short-term (0 INR) and long-term (1.5B INR) debt.
You can find a full breakdown on its Balance Sheet.
